Cargando…
The roles of ARID1A in gynecologic cancer
One of the exciting findings in recent cancer genome studies is the discovery of somatic mutations in several chromatin remodeling genes. These studies not only illuminate the emerging roles of chromatin remodeling in the pathogenesis of human cancer but also provide molecular genetic basis of aberr...
Autores principales: | Mao, Tsui-Lien, Shih, Ie-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805919/ https://www.ncbi.nlm.nih.gov/pubmed/24167674 http://dx.doi.org/10.3802/jgo.2013.24.4.376 |
Ejemplares similares
-
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010) -
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
por: Ayhan, Ayse, et al.
Publicado: (2015) -
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
por: Mandal, Jayaprakash, et al.
Publicado: (2022) -
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
por: Fukumoto, Takeshi, et al.
Publicado: (2018) -
Targeting EZH2 methyltransferase activity in ARID1A mutated cancer cells is synthetic lethal
por: Biter, Benjamin G., et al.
Publicado: (2015)